ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2016
[Complete Single-Utility-Port Thoracoscopic Resection of Lung Cancer with Single-Rib Metastasis].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Thoracoscopic Lobectomy versus Segmentectomy in the Treatment of Patients with Early-Stage Lung Cancer.Evidence-based complementary and alternative medicine : eCAM · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplete thoracoscopic surgery has advanced, and its indication has also been extended to complex procedures. The aim of this study is to investigate the feasibility of complete single-utility-port thoracoscopic lobectomy with rib resection.
methodsA patient was diagnosed with lung cancer and single-rib metastasis. The patient received lobectomy and segment costectomy through complete single-utility-port thoracoscopic surgery. The literature was also reviewed.
resultsThe tumor was staged at T1N1M1. The patient made an uneventful recovery and was dismissed on day 4 after surgery. At the last follow-up, the patient was alive and well, with no evidence of the disease at 18 months postoperatively.
conclusionsHighly selected cases of lung cancer with single-rib metastasis are appropriate candidates for complete single-utility-port thoracoscopic resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.